Microbial resistance to drug therapy: A review

American Journal of Infection Control

Volumn 25, Issue 1, 1997, Pages 51-64

  Cohen, Felissa L ^a   Tartasky, Donna ^a  

^a SOUTHERN ILLINOIS UNIVERSITY EDWARDSVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; DISEASE TRANSMISSION; HOSPITAL; HOSPITAL INFECTION; INFECTION CONTROL; INFECTION PREVENTION; NONHUMAN; PREVALENCE; REVIEW;

EID: 0031048673     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-6553(97)90054-7     Document Type: Article

References (114)

1. Nash JM. Attack of the superbugs. Time 1992;140(9):62-3.
2. Manning A. Menacing microbes: drug resistance fuels threat of "killer" bugs. USA Today 1995 Sept 19;Sect D:1.
3. Bartlett JG, Froggatt JW. Antibiotic resistance. Arch Otolaryngol Head Neck Surg 1995;121:392-6.
4. Rex JH, Rinaldi MG, Pfaller MA. Resistance of Candida species to fluconazole. Antimicrob Agents Chemother 1995;39:1-8.
5. Richman DD. Clinical significance of drug resistance in human immunodeficiency virus. Clin Infect Dis 1995; 21(Suppl 2):S166-9.
6. Dixon DM, McNeil MM, Cohen ML, Gellin BG, LaMontagne JR. Fungal infections: a growing threat. Public Health Rep 1996;111:226-35.
7. White NJ. The treatment of malaria. N Engl J Med 1996;335:800-6.
8. Goldmann DA, Weinstein RA, Wenzel RP, Tablan OC, Duma RJ, Gaynes R, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. JAMA 1996;275:234-40.
9. Cohen ML. Epidemiology of drug resistance: implications for a post-antimicrobial era. Science 1992;257:1050-5.
10. Centers for Disease Control and Prevention. Defining the public health impact of drug-resistant Streptococcus pneumonias: report of a working group. MMWR 1996; 45(RR-1):1-20.
11. Felmingham D. Antibiotic resistance: do we need new therapeutic approaches? Chest 1995;108(Suppl):70S-8S.
12. Tomasz A. Multiple antibiotic-resistant pathogenic bacteria: a report on the Rockefeller University workshop. N Engl J Med 1994;330:1247-52.
13. Péchère JC. Antibiotic resistance is selected primarily in our patients. Infect Control Hosp Epidemiol 1994; 15:472-7.
14. Kunin CM, Lipton HL, Tupasi T, Sacks T, Scheckler WE, Jivani A. Social, behavioral and practical factors affecting antibiotic use worldwide: report of task force 4. Rev Infect Dis 1987;9(Suppl 3):S270-85.
15. Madsen L, Cohen FL. Medical treatment of tuberculosis. In: Cohen FL, Durham JD, editors. Tuberculosis: a sourcebook for nursing practice. New York: Springer Publishing, 1995:67-97.
16. Cohen ML. Emerging problems of antimicrobial resistance. Ann Emerg Med 1994;24:454-6.
17. Sumartojo E. Adherence to the tuberculosis treatment plan. In: Cohen FL, Durham JD, editors. Tuberculosis: a sourcebook for nursing practice. New York: Springer Publishing, 1995:121-36.
18. Neu HC. Emerging trends in antimicrobial resistance in surgical infections. Eur J Surg 1994;(Suppl 573):7-18.
19. Vandenbroucke-Grauls CM. The threat of multiresistant microorganisms. Eur J Clin Microbiol Infect Dis 1993;12(Suppl 1):27-30.
20. Rosebury T. Microbes and morals. New York: Viking Press, 1971.
21. Abraham EP, Chain E. An enzyme from bacteria able to destroy penicillin. Nature 1940;146:837-9.
22. Kirby WM. Extraction of a highly potent penicillin inactivator from penicillin-resistant staphylococci. Science 1944;99:452-5.
23. Lowbury EJ, Ayliffe GA. Drug resistance in antimicrobial therapy. Springfield (IL): Charles C Thomas, 1974.
24. Centers for Disease Control. Nosocomial transmission of multidrug-resistant tuberculosis to health-care workers and HIV-infected patients in an urban hospital - Florida. MMWR 1990;39:718-22.
25. Shlaes DM, Binczewski B, Rice LB. Emerging antimicrobial resistance and the immunocompromised host. Clin Infect Dis 1993;17(Suppl 2):S527-36.
26. Schentag JJ. Understanding and managing microbial resistance in institutional settings. Am J Health Syst Pharm 1995;52(Suppl 2):S9-14.
27. Stephens DS, Farley MM. Editorial. Am J Med Sci 1996;311:1-2.
28. Burns JL. Mechanisms of bacterial resistance. Pediatr Clin North Am 1995;42:497-507.
29. Berkowitz FE. Antibiotic resistance in bacteria. South Med J 1995;88:797-804.
30. Neu HC. Emergence and mechanisms of bacterial resistance in surgical infections. Am J Surg 1995;169:(Suppl 5A)13S-20S.
31. Neu HC. The crisis in antibiotic resistance. Science 1992;254:1064-73.
32. Fraimow HS, Abrutyn E. Pathogens resistant to antimicrobial agents. Infect Dis Clin North Am 1995;9:497-530.
33. Meyers BR. Bacterial resistance: exploring the facts and myths. Bull N Y Acad Med 1987;63:211-6.
34. Holmberg SD, Solomon SL, Blake PA. Health and economic impacts of antimicrobial resistance. Rev Infect Dis 1987;9:1065-78.
35. Garrett L. The coming plague. New York: Farrar, Straus and Giroux, 1994.
36. Weinstein RA. Epidemiology and control of nosocomial infections in adult intensive care units. Am J Med 1991(Suppl 3B):179S-84S.
37. Riley TV. Antimicrobial resistance in Branhamella catarrhalis. J Antimicrob Chemother 1988;21:147-50.
38. Small PM, Shafer RW, Hopewell PC, Singh SP, Murphy MJ, Desmond E, et al. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. N Engl J Med 1993; 328:1137-44.
39. Gardner P, Smith DH, Beer H, Moellering RC Jr. Recovery of resistance (R) factors from a drug-free community. Lancet 1969;2:774-6.
40. Speer BS, Shoemaker NB, Salyers AA. Bacterial resistance to tetracycline: mechanisms, transfer and clinical significance. Clin Microbiol Rev 1992;5:387-99.
41. Mayer KH. Review of epidemic aminoglycoside resistance worldwide. Am J Med 1986;80(Suppl 6B):56-64.
42. Tenover FC, McGowan JE Jr. Reasons for the emergence of antibiotic resistance. Am J Med Sci 1996;311:9-16.
43. Hayward CM, Griffin GE. Antibiotic resistance: the current position and the molecular mechanisms involved. Br J Hosp Med 1994;52:473-8.
44. Levy SB. Confronting multidrug resistance: a role for each of us. JAMA 1993;269:1840-2.
45. Anderson RL. Iodophor antiseptics: intrinsic microbial contamination with resistant bacteria. Infect Control Hosp Epidemiol 1989;10:443-6.
46. Nikaido H. Prevention of drug access to bacterial targets: permeability barriers and active reflux. Science 1994; 264:382-8.
47. Rosenberg J. Methicillin resistant Staphylococcus aureus (MRSA) in the community: who's watching? Lancet 1995;346:132-3.
48. Swartz MN. Hospital-acquired infections: diseases with increasingly limited therapies. Proc Natl Acad Sci USA 1994;91:2420-7.
49. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991;91(Suppl 3B):72S-5S.
50. Zervos MJ, Kauffman CA, Therasse PM, Bergman AC, Mikesell TS, Schaberg DR. Nosocomial infection by gentamicin-resistant Streptococcus faecalis: an epidemiologic study. Ann Intern Med 1987;106:687-91.
51. Schaberg DR, Dillon WI, Terpenning MS, Robinson KA, Bradley SF, Kauffman CA. Increasing resistance of enterococci to ciprofloxacin. Antimicrob Agents Chemother 1992;36:2533-5.
52. Centers for Disease Control and Prevention. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR 1995;44(RR-12:)1-13.
53. Livornese LL Jr, Dias S, Samel C, et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med 1992;117:112-6.
54. Boyce JM, Opal SM, Chow JW, Standiford HC, John JF, Korvick JA. Outbreak of multi-drug resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 1994;32:1148-53.
55. Tenover FC, Hughes JM. The challenges of emerging infectious diseases: development and spread of multiplyresistant bacterial pathogens. JAMA 1996;275:300-4.
56. Tenover FC. Novel and emerging mechanisms of antimicrobial resistance in nosocomial pathogens. Am J Med 1991;91:(Suppl 3B)76S-81S.
57. Doebbeling BN. The epidemiology of methicillin-resistant Staphylococcus aureus colonisation and infection. J Chemother 1995;7(Suppl 3):99-103.
58. Coll PP, Nurse BA. Implications of methicillin-resistant Staphylococcus aureus on nursing home practice. J Am Board Fam Pract 1992;5:193-200.
59. Martin MA. Methicillin-resistant Staphylococcus aureus: the persistent resistant nosocomial pathogen. Curr Clin Top Infect Dis 1994;14:170-91.
60. Brumfitt W, Hamilton-Miller JM. The challenge of methicillin-resistant Staphylococcus aureus. Drugs Exp Clin Res 1994;20:215-24.
61. Johnston BL. Methicillin-resistant Staphylococcus aureus as a cause of community-acquired pneumonia - a critical review. Semin Respir Infect 1994;9:199-206.
62. Boyce JM, Jackson MM, Pugliese G, Batt MD, Fleming D, Garner JS, et al. Methicillin-resistant Staphylococcus aureus (MRSA): a briefing for acute care hospitals and nursing facilities. Infect Control Hosp Epidemiol 1994; 15:105-15.
63. Boyce JM. Methicillin-resistant Staphylococcus aureus in hospitals and long-term care facilities: microbiology, epidemiology, and preventive measures. Infect Control Hosp Epidemiol 1992;13:725-37.
64. Mulligan ME, Murray-Leisure KA, Ribner BS, et al. Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med 1993;94:313-28.
65. Sanders CC, Sanders WE Jr, Thomson KS. Fluoroquinolone resistance in staphylococci: new challenges. Eur J Clin Microbiol Infect Dis 1995;14(Suppl 1):S6-11.
66. de Vera ME, Simmons RL. Antibiotic-resistant enterococci and the changing face of surgical infections. Arch Surg 1996;131:338-42.
67. Edmond MB, Wenzel RP, Pasculle AW. Vancomycin-resistant Staphylococcus aureus: perspectives on measures needed for control. Ann Intern Med 1996;124:329-34.
68. Murray BE. New aspects of antimicrobial resistance and the resulting therapeutic dilemma. J Infect Dis 191;163:1185-94.
69. Whiteford ML, Wilkinson JD, McColl JH, Conlon FM, Michie JR, Evans TJ, et al. Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak. Thorax 1995; 50:1194-8.
70. Henderson VJ, Hirvela ER. Emerging and reemerging microbial threats. Nosocomial fungal infections. Arch Surg 1996;131:330-7.
71. Beck-Sague C, Jarvis WR. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect Dis 1993; 167:1247-51.
72. Fisher-Hoch SP, Hutwagner L. Opportunistic candidiasis: an epidemic of the 1980s. Clin Infect Dis 1995;21:897-904.
73. Mahayni R, Vazauez JA, Zervos MJ. Nosocomial candidiasis: epidemiology and drug resistance. Infect Agents Disease 1995;4:248-53.
74. Banerjee SN, Emori TG, Culver DH, Gaynes RP, Jarvis WR, Horan T, et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. Am J Med 1991;91(Suppl 3B):86S-9S.
75. Pertowski CA, Baron RC, Lasker BA, Werner SB, Jarvis WR. Nosocomial outbreak of Candida albicans sternal wound infections following cardiac surgery traced to a scrub nurse. Infect Dis 1995;172:817-22.
76. Centers for Disease Control. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons - Florida and New York, 1988-1991. MMWR 1991;40:585-91.
77. Dooley SW, Villarino ME, Lawrence M, Salinas L, Amil S, Rullan JV, et al. Nosocomial transmission of tuberculosis in a hospital unit for HIV-infected patients. JAMA 1992;267:2632-5.
78. Jarvis WR. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. Res Microbiol 1993; 44:117-22.
79. Cohen FL. The epidemiology of tuberculosis. In: Cohen FL, Durham JD, editors. Tuberculosis: a sourcebook for nursing practice. New York: Springer Publishing, 1995: 29-51.
80. Strausbaugh LJ, Crossley KB, Nurse BA, Thurpp LD, SHEA Long-Term-Care Committee. Antimicrobial resistance in long-term care facilities. Infect Control Hosp Epidemiol 1996;17:129-40.
81. Terpenning MS, Bradley SF, Wan JY, Chenoweth CE, Jorgensen KA, Kauffman CA. Colonization and infection with antibiotic-resistant bacteria in a long-term care facility. J Am Geriatr Soc 1994;42:1062-9.
82. Reichler MR, Allphin AA, Breiman RF, Schreiber JR, Arnold JA, McDougal LK. The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio. J Infect Dis 1992;166:1346-53.
83. Rauch AM, O'Ryan M, Van R, Pickering LK. Invasive disease due to multiply resistant Streptococcus pneumoniae in a Houston, Tex, day-care center. Am J Dis Child 1990;144:923-7.
84. Pinner RW. Addressing the challenges of emerging infectious diseases. Am J Med Sci 1996;311:3-8.
85. Patwari AK. Multidrug resistant Shigella infections in children. J Diarrhoeal Dis Rev 1994;12:182-6.
86. Wayne SJ, Rhyne RL, Stratton M. Longitudinal prescribing patterns in a nursing home population. J Am Geriatr Soc 1992;17:119-28.
87. Nicolle LE, Bentley D, Garibaldi R, Neuhaus E, Smith P, SHEA Long-Term Care Committee. Antimicrobial use in long-term-care facilities. Infect Control Hosp Epidemiol 1996;17:119-28.
88. Lonks JR, Medeiros AA. The growing threat of antibiotic-resistant Streptococcus pneumoniae. Med Clin North Am 1995;79:523-35.
89. Musher DM. Pneumococcal pneumonia including diagnosis and therapy of infection caused by penicillin-resistant strains. Infect Dis Clin North Am 1991;5:509-21.
90. Gray BM, Converse GM 3rd, Dillon HC Jr. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J Infect Dis 1980;142:923-33.
91. Bluestone CD. Surgical management of otitis media:current indications and role related to increasing bacterial resistance. Pediatr Infect Dis J 1994;13:1058-63.
92. McCracken GH. Emergence of resistant Streptococcus pneumoniae: a problem in pediatrics. Pediatr Infect Dis J 1995;14:424-8.
93. Kronberger CB, Hoffman RE, Lezotte DC, Marine WM. Invasive penicillin-resistant pneumococcal infections: a prevalence and historical cohort study. Emerging Infect Dis 1996;2(2):121-4.
94. McGowan JE, Metchock BG. Penicillin-resistant pneumococci-an emerging threat to successful therapy. J Hosp Infect 1995;30:472-82.
95. Centers for Disease Control and Prevention. Fluoroquinolone resistance in Neisseria gonorrhoeae - Colorado and Washington. MMWR 1995;44(41):761-4.
96. Farrar WE. Antibiotic resistance in developing countries. J Infect Dis 1985;152:1103-6.
97. Lester SC, Del Pilar Pua M, Wang F, Schael IP, Jiang H, O'Brien TF. The carriage of Escherichia coli resistant to antimicrobial agents by healthy children in Boston, in Caracas, Venezuela, and in Qin Pu, China. N Engl J Med 1990;323:285-9.
98. Hospital Infection Control Practices Advisory Committee. Guideline for prevention of nosocomial pneumonia: part II. Recommendations for prevention of nosocomial pneumonia. AJIC Am J Infect Control 1994;22:266-92.
99. Hospital Infection Control Practices Advisory Committee. Guidelines for isolation precautions in hospitals: Part II. Recommendations for isolation precautions in hospitals. AJIC Am J Infect Control 1996; 24:32-52.
100. Larson EL, 1992, 1993 and 1994 APIC Guideline Committee. APIC guidelines for handwashing and hand antisepsis in health care settings AJIC Am J Infect Control 1995;23:251-69.
101. Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities. MMWR 1994;43(RR-13):1-133.
102. Association of Operating Room Nurses. Recommended practices: surgical hand scrubs. AORN J 1990;52:830-6.
103. Department of Health and Human Services and Department of Labor. Respiratory protective devices; final rules and notice. Fed Reg 1995;60(110):30336-402.
104. Centers for Disease Control and Prevention. Recommended childhood immunization schedule: United States, January 1995. MMWR 1995;43:959-60.
105. Fedson DS. Adult immunization: summary of the National Vaccine Advisory Committee report. JAMA 1994;272:1133-7.
106. Gindler J, Phillips CF, Schaffner W, Williams WW. Immunization effective at all ages. Patient Care 1995; 29(9):119-34.
107. O'Brien TF, Stelling JM. WHONET: an information system for monitoring antimicrobial resistance. Emerging Infect Dis 1996;1:1-2.
108. Voelker R. New group tracks hospitals' drug-resistant bugs. JAMA 1996;275:177-8.
109. McCaig LF, Hughes JM. Trends in antibiotic prescribing among office-based physicians in the United States. JAMA 1995;273:214-9.
110. Cohen ML, Dorman NJ, Kauffman CA, Thornsberry C. Antimicrobial resistance: are the pathogens winning? Patient Care 1995;29(9):56-69.
111. Anonymous. Shame on you! Wash your hands! Especially you 40% at Penn Station. New York Times 1996 Sept 17;Sect C:3.
112. Stephenson J. Icelandic researchers are showing the way to bring down rates of antibiotic-resistant bacteria. JAMA 1996;275;175.
113. Koontz FP. A review of traditional resistance surveillance methodologies and infection control. Diagn Microbiol Infect Dis 1992;15:43S-7S.
114. Raad I, Darouiche R, Hachem R, Mansouri M, Bodey GP. The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin. J Infect Dis 1996;173:418-24.